Janux Therapeutics, Inc.

JANX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$430,605$19,205$51,426$35,582
Short-Term Investments$594,568$324,823$275,590$339,383
Receivables$5,381$0$700$0
Inventory$0$0-$700$0
Other Curr. Assets$3,112$5,213$5,423$2,054
Total Curr. Assets$1,033,666$349,241$332,439$377,019
Property Plant & Equip (Net)$24,150$27,841$29,365$1,597
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$816$0
Tax Assets$0$0$0$0
Other NC Assets$3,700$3,325$1,390$1,208
Total NC Assets$27,850$31,166$31,571$2,805
Other Assets$0$0$0$0
Total Assets$1,061,516$380,407$364,010$379,824
Liabilities
Payables$4,026$2,424$2,159$2,458
Short-Term Debt$1,749$1,517$763$194
Tax Payable$0$0$0$0
Deferred Revenue$0$1,705$5,406$5,163
Other Curr. Liab.$11,684$7,387$8,179$4,982
Total Curr. Liab.$17,459$13,033$16,507$12,797
LT Debt$21,276$23,025$24,542$0
Deferred Rev, NC$0$0$2,221$700
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$21,276$23,025$26,763$700
Other Liabilities$0$0$0$0
Cap. Leases$23,025$24,542$25,305$194
Total Liabilities$38,735$36,058$43,270$13,497
Equity
Pref Stock$0$0$0$0
Common Stock$59$46$42$41
Retained Earnings-$237,757-$168,763-$110,470-$47,411
AOCI$2,163$665-$1,535-$270
Other Equity$1,258,316$512,401$432,703$413,967
Total Equity$1,022,781$344,349$320,740$366,327
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,061,516$380,407$364,010$379,824
Net Debt-$407,580$5,337-$26,121-$35,388